Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 244,716 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
antiviral
Antivirals in medical biodefense.
J J Bugert, F Hucke, P Zanetta, M Bassetto, A Brancale
Virus Genes
. Apr, 2020.56(2):150-167 Print-Electronic
Source:PubMed
PMID:
32076918
doi:10.1007/s11262-020-01737-5
Lipoproteins account for part of the broad non-specific antiviral activity of human serum.
I P Singh, A K Chopra, D H Coppenhaver, G M Ananatharamaiah, S Baron
Antiviral Res
. Jul, 1999.42(3):211-8 Print
Source:PubMed
PMID:
10443533
doi:10.1016/s0166-3542(99)00032-7
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition).
Hugh J Field
Antivir Chem Chemother
. 2008.19(2):49-50 Print
Source:PubMed
PMID:
18727439
doi:10.1177/095632020801900202
The role of antiviral treatment in curbing the COVID-19 pandemic: a modeling study.
Matrajt, L.; Brown, E. R.; Dimitrov, D.; Janes, H.
medrxiv
. 2021-11-11. Preprint
Source:medrxiv
PPRID:
10.1101/2021.11.10.21266139v1
doi:NA
Inhibitors compounds of the flavivirus replication process.
Leidy L García, Leonardo Padilla, Jhon C Castaño
Virol J
. 05 15, 2017.14(1):95 Electronic
Source:PubMed
PMID:
28506240
doi:10.1186/s12985-017-0761-1
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2006 (1st edition).
Erik De Clercq, Andrea Brancale, Anthony Vere Hodge, Hugh J Field
Antivir Chem Chemother
. 2006.17(3):113-66 Print
Source:PubMed
PMID:
16956068
doi:10.1177/095632020601700302
5-substituted deoxyuridines--structural requirements for antiviral activity against herpes simplex virus types 1 and 2 and possible biochemical basis for relative potency.
I S Sim, R H Raper
Antiviral Res
. Jun, 1984.4(3):159-68 Print
Source:PubMed
PMID:
6089658
doi:10.1016/0166-3542(84)90015-9
Potential targets for antiviral chemotherapy.
W H Prusoff, T S Lin, M Zucker
Antiviral Res
. Oct, 1986.6(6):311-28 Print
Source:PubMed
PMID:
3535669
doi:10.1016/0166-3542(86)90014-8
Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro.
Emanuel Haasbach, Carmen Hartmayer, Oliver Planz
Antiviral Res
. May, 2013.98(2):319-24 Print-Electronic
Source:PubMed
PMID:
23523553
doi:10.1016/j.antiviral.2013.03.006
Advanced virtual screening enables the discovery of a host-targeting and broad-spectrum antiviral agent.
Garri Chilingaryan, Roza Izmailyan, Rafayela Grigoryan, Anastasiya Shavina, Erik Arabyan, Hamlet Khachatryan, Narek Abelyan, Mher Matevosyan, Vardan Harutyunyan, Gayane Manukyan, Benjamin Hietel, Anna Shtro, Daria Danilenko, Hovakim Zakaryan
Antiviral Res
. 09, 2023.217:105681 Print-Electronic
Source:PubMed
PMID:
37499699
doi:10.1016/j.antiviral.2023.105681
0
Previous
Next